A Phase III Clinical Trial for Efficacy and Safety Evaluation of JP-1366 Tablets on Reflux Esophagitis

Clinical trial NCT06850480 · RECRUITING

Trial details

NCT number: NCT06850480
Sponsor: Livzon Pharmaceutical Group Inc.
Status: RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Reflux Esophagitis (RE)

Start date: 2024-12-05
Primary completion: 2025-04-15
Enrollment: 356

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.